- Q1 2024 Biomx Inc Earnings Call TranscriptMay 21, 2024$0.365 (+6.85%)Earnings
- Q4 2023 Biomx Inc Earnings Call TranscriptApr 03, 2024$0.35 (-8.90%)Earnings
- Q2 2023 Biomx Inc Earnings Call TranscriptAug 09, 2023$0.3806 (-9.29%)Earnings
- Q1 2023 Biomx Inc Earnings Call TranscriptMay 15, 2023$0.299 (+7.17%)Earnings
- Q4 2022 Biomx Inc Earnings Call TranscriptMar 29, 2023$0.32 (+2.24%)Earnings
- Biomx Inc Corporate Call TranscriptFeb 22, 2023
- Q3 2022 Biomx Inc Earnings Call TranscriptNov 09, 2022$0.325 (-4.38%)Earnings
- Biomx Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Biomx Inc Annual Shareholders Meeting TranscriptAug 24, 2022
- Q2 2022 Biomx Inc Earnings Call TranscriptAug 10, 2022$0.73 (-6.41%)Earnings
- Q1 2022 Biomx Inc Earnings Call TranscriptMay 11, 2022$0.9 (-6.09%)Earnings
- Q4 2021 Biomx Inc Earnings Call TranscriptMar 30, 2022$1.75 (+14.38%)Earnings
- Q3 2021 Biomx Inc Earnings Call TranscriptNov 15, 2021$2.37 (-4.82%)Earnings
- Q2 2020 Biomx Inc Earnings Call TranscriptAug 13, 2020$6.67 (-16.42%)Earnings
Biomx Inc Corporate Call Transcript
Good morning and welcome to the BiomX conference call to discuss results from the company's ongoing Phase 1b/2a trial in cystic fibrosis. (Operator Instructions)
I would now like to turn the call over to Marina Wolfson, Chief Financial Officer of BiomX. Please proceed.
Thank you for joining us today to discuss the results from Part 1 of our ongoing Phase 1b/2a trial evaluating BX004 for the treatment of Pseudomonas aeruginosa infections in patients with cystic fibrosis or CF.
Earlier today, BiomX issued a press release detailing results from Part 1 of our study and became available just after 6:30 AM Eastern Time and can be found on our website at biomx.com. A replay of this call will be available on the Investors section of our website.
Before we begin, I'd like to review the Safe Harbor provision. All statements on this call that are not factual historic statements may be deemed forward-looking statements.
For instance, we're using forward-looking statements when we discuss in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)